ATE530907T1 - Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor - Google Patents

Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor

Info

Publication number
ATE530907T1
ATE530907T1 AT08716004T AT08716004T ATE530907T1 AT E530907 T1 ATE530907 T1 AT E530907T1 AT 08716004 T AT08716004 T AT 08716004T AT 08716004 T AT08716004 T AT 08716004T AT E530907 T1 ATE530907 T1 AT E530907T1
Authority
AT
Austria
Prior art keywords
inhibitory activity
assessing
receptor
growth factor
antibodies against
Prior art date
Application number
AT08716004T
Other languages
English (en)
Inventor
Stefan Evers
Andreas Hinz
Klaus-Peter Kuenkele
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE530907T1 publication Critical patent/ATE530907T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08716004T 2007-02-27 2008-02-25 Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor ATE530907T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07003948 2007-02-27
PCT/EP2008/001457 WO2008104344A1 (en) 2007-02-27 2008-02-25 Method for the assessment of the inhibitory activity of antibodies against insulin-like growth factor i receptor

Publications (1)

Publication Number Publication Date
ATE530907T1 true ATE530907T1 (de) 2011-11-15

Family

ID=38108609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08716004T ATE530907T1 (de) 2007-02-27 2008-02-25 Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor

Country Status (8)

Country Link
US (1) US20100323373A1 (de)
EP (1) EP2126565B1 (de)
JP (1) JP2010517024A (de)
CN (1) CN101617228A (de)
AT (1) ATE530907T1 (de)
CA (1) CA2677901A1 (de)
ES (1) ES2375242T3 (de)
WO (1) WO2008104344A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008307579A1 (en) 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
CA2694154A1 (en) 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US9896730B2 (en) 2011-04-25 2018-02-20 OSI Pharmaceuticals, LLC Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
ZA898290B (en) 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
EP2796468A2 (de) * 2001-01-05 2014-10-29 Pfizer Inc Antikörper für Insulinähnlichen Wachstumsfaktor-1-Rezeptor
US7378503B2 (en) 2003-04-02 2008-05-27 Hoffmann-La Roche Inc. Antibodies against insulin-like growth factor 1 receptor and uses thereof
US7579157B2 (en) 2003-07-10 2009-08-25 Hoffmann-La Roche Inc. Antibody selection method against IGF-IR

Also Published As

Publication number Publication date
US20100323373A1 (en) 2010-12-23
CN101617228A (zh) 2009-12-30
EP2126565A1 (de) 2009-12-02
JP2010517024A (ja) 2010-05-20
ES2375242T3 (es) 2012-02-28
EP2126565B1 (de) 2011-10-26
CA2677901A1 (en) 2008-09-04
WO2008104344A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
WO2008122789A3 (en) Methods for modulating lrrk2
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
EP2534257A4 (de) Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden
CL2008003561A1 (es) Construccion de union a il - 13 que comprende a lo menos un dominio simple (dab) de anticuerpo injertado en un anticuerpo monoclonal ( mabdab); polinucleotido y celula huesped; procedimiento para preparar la construccion; composicion farmaceutica que la comprende y uso para tratar cancer o enfermedades inflamatorias.
EA201190210A1 (ru) Ингибиторы связывания киназы с белком
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
ATE443870T1 (de) Verfahren zur charakterisierung einer polyklonalen zellinie
AT505105A3 (de) Verfahren zur beurteilung der fahrbarkeit von fahrzeugen
ATE454632T1 (de) Verfahren zur beurteilung der lebensfähigkeit von embryos
WO2007120638A3 (en) Methods and compositions for modulating glycosylation
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
ATE550645T1 (de) Verfahren zur zerstörungsfreien prüfung von rohren
EP4021499A4 (de) Anti-il31-antikörper zur verwendung in der veterinärmedizin
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
EP3486652C0 (de) Verfahren zur identifizierung einer biologischen probe eines säugers, zusammensetzung zur verwendung in diesem verfahren und kit zur durchführung dieses verfahrens
MX2010002994A (es) Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos.
ATE530907T1 (de) Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
EP1877785A4 (de) Verfahren zur messung der glycanniveaus von proteinen
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
GB2463656B (en) Substrate of LRRK2 and methods of assessing LRRK2 activity
DK2005190T3 (da) Inhibering af gasc1
WO2010035259A3 (en) Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
DE602004017884D1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE535546T1 (de) Humane monoklonale antikörper, die spezifisch an ifg-ii binden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties